Apollo Endosurgery, Inc.

Biotronik Se Co. Kg

Apollo Endosurgery Us, Inc.

Joseph S Raven

Christopher S Mudd

Mitchell H Babkes

Zachary Dominguez

Justin J Schwab

Sean Snow

Babak Honaryar

Marcos Borrell

Tiago Bertolote

Dirk Muessig

Janel A Birk

Futian Liu

Brian M Taff

Andrew B Kibler

Larry Stotts

Jeffrey A Von Arx

Robert E Hoyt, Jr

Dimitrios Stroumpoulis

Kurt Swenson

Mike Augarten

Philip Bryer

Paul Stadnik

Nikhil S Trilokekar

Christian Y Perron

Vernon Vincent

Yu Wang

Ulrich Hugel

James A Harders

Jeff Allen

Vern L Vincent

Zachary P Dominguez

Jr Robert E Hoyt

Kaustubh Chitre

Technology for near infrared (NIR) based communication and/or sensing of implantable medical devices and systems as well as method of operating the same.

Implantable medical devices and systems with communication/sensing based on near infrared signals

An intravascular electrode lead and an intravascular stimulation device including the same. The intravascular electrode lead includes an electrode shaft; a plurality of filaments being made of a conductive, non-biodegradable material, running in longitudinal direction within the electrode shaft and protruding distally beyond a distal end of the electrode shaft, each filament terminating in at least one electrically active area; and a support member being arranged distally from the distal end of the electrode shaft and being dilatable from a compressed state to an radially expanded state, wherein the support member is attached to the filaments and made of a biodegradable material.

Intravascular electrode lead and intravascular stimulation device including the same

A transorally implanted intragastric balloon or treating obesity and for weight control including a variable size balloon with one or interconnected regions acting to exert a pressure on the stomach, to provide a stomach volume occupying effect, and/or to anchor the balloon within the stomach.

Intragastric balloon for treating obesity

Intragastric fluid transfer devices and related methods for operation thereof are disclosed. The intragastric fluid transfer devices and related methods are intended to assist a patient in maintaining a healthy body weight by stimulating the inner stomach walls and/or the inner duodenum walls. Features of the intragastric fluid transfer device include insertion of the devices transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The life span of these intragastric fluid transfer devices may be material-dependent upon long-term survivability within an acidic stomach, but is intended to last one year or longer.

Intragastric implants with duodenal anchors

The present specification discloses porous materials, methods of forming such porous material, biocompatible implantable devices comprising such porous materials, and methods of making such biocompatible implantable devices. The porous material may be used to fix to the interior mucosal lining of a patient's gastrointestinal tract.

Mucosal tissue adhesion via textured surface

A self-adjusting gastric band applies a substantially constant force to a patient's fundus in order to facilitate weight control. The self-adjusting gastric band is capable of automatically relaxing and contracting in response to changes in the patient's fundus or in response to a large bolus passing through the patient's fundus that is constricted by the gastric band. The self-adjusting gastric band is automatically adjustable without hydraulic fluid and without external physician intervention. The self-adjusting gastric band comprises a movable member and a biasing mechanism coupled to the movable member to facilitate applying the substantially constant force against the fundus as the fundus changes size, shape and/or position.

Self-adjusting mechanical gastric band

An intraluminal sleeve system is provided, which generally includes an intraluminal sleeve capable of dispensing an active agent to a patient, for example, a metabolic agent or satiety inducing agent. The intraluminal sleeve may be structured to contain the active agent and permit controlled release of the active agent to the patient while the intraluminal sleeve is positioned within the patient's intestine. Methods for treating obesity are also provided which include positioning an intraluminal sleeve in a patient's intestine, the intraluminal sleeve being capable of dispensing an active agent to the patient. In one embodiment, the active agent may be contained in a reservoir and dispensed to a portion of the patient's body.

Intraluminal sleeve with active agents

An implantable injection port facilitates filling and/or draining an inflatable portion of a gastric band. In an embodiment, the port comprises a movable cap that causes anchor wires to extend from anchor devices in order to implant the injection port in the tissue of a patient. In another embodiment, the port comprises a handle that rotates to implant curved anchors into the tissue of a patient. In yet another embodiment, a cap is configured to move towards a base of the port in order to cause the curved anchors to rotate into the tissue of a patient. The cap may also rotate with respect to the base in order to lock the cap and the anchors in position. Further, surfaces of the injection port may be textured to increase adhesiveness to the patient's tissue during installation and to facilitate simpler installation.

Implantable injection port

The present invention includes a source reservoir with potential energy for a system for facilitating obesity control. The system includes a remote transmitter, a gastric band including at least one inflatable portion for containing a fluid, at least one reservoir for containing the fluid, and a high precision pump unit in communication with the reservoir for controlling pressure within the inflatable portion.

Source reservoir with potential energy for remotely adjustable gastric banding system

The present invention provides a system for attaching a fluid access port to a patient. The system generally comprises an implantable access port with a bottom exit port and method for attaching an access port to a patient. In addition, a tube guard, flexible tube exit port, tissue guard, and porous coupling member are disclosed.

Implantable bottom exit port

The present invention provides a system for attaching a fluid access port to a patient. The system generally comprises an implantable access port and method for attaching an access port to a patient. In addition, a tube guard, tube shroud, tissue guard, porous coupling member and a prefabricated mesh member may be attached to the access port. For example, the prefabricated mesh may be coupled to the access port to facilitate securing the access port to the tissue of the patient.

Implantable coupling device

Growing community of inventors

Goleta, CA, United States of America

Joseph S Raven